Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets

Journal of Virology

Volumn 88, Issue 3, 2014, Pages 1652-1658

  Abed, Yacine ^a   Pizzorno, Andrés ^a   Bouhy, Xavier ^a   Rhéaume, Chantal ^a   Boivin, Guy ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; VIRUS SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FERRET; IN VITRO STUDY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE GENETICS; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; WEIGHT REDUCTION;

AMINO ACID MOTIFS; ANIMALS; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; FERRETS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MICE; MICE, INBRED C57BL; MUTATION, MISSENSE; NEURAMINIDASE; OSELTAMIVIR; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 84892467702     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02681-13     Document Type: Article

References (35)

1. Reid AH, Janczewski TA, Lourens RM, Elliot AJ, Daniels RS, Berry CL, Oxford JS, Taubenberger JK. 2003. 1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. Emerg. Infect. Dis. 9:1249-1253. http://dx.doi.org/10.3201/eid0910.020789.
2. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122-1125. http://dx.doi.org/10.1038/nature08182.
3. Committee on Infectious Diseases of the American Academy of Pediatrics. 2012. Recommendations for prevention and control of influenza in children, 2012-2013. Pediatrics 130:780-792. http://dx.doi.org/10.1542/peds.2012-2308.
4. WHO. 2012. Review of the 2011-2012 winter influenza season, northern hemisphere. Wkly. Epidemiol. Rec. 87:233-240. http://www.who.int/wer/2012/wer8724.pdf.
5. CDC. 2013. Influenza activity-United States, 2012-13 season and composition of the 2013-14 influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 62:473-479. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6 223a5.htm.
6. Graitcer SB, Gubareva L, Kamimoto L, Doshi S, Vandermeer M, Louie J, Waters C, Moore Z, Sleeman K, Okomo-Adhiambo M, Marshall SA, St George K, Pan CY, LaPlante JM, Klimov A, Fry AM. 2011. Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg. Infect. Dis. 17:255-257. http://dx.doi.org/10.3201/eid1702.101724.
7. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. 2009. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N. Engl. J. Med. 361:2296-2297. http://dx.doi.org/10 .1056/NEJMc0910060.
8. Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, Hayden FG, Hui DS, Hungnes O, Lackenby A, Lim W, Meijer A, Penn C, Tashiro M, Uyeki TM, Zambon M. 2012. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect. Dis. 12:240-248. http://dx.doi.org/10.1016/S1473-3099(11)70318-8.
9. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM. 2009. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301:1034-1041. http://dx.doi .org/10.1001/jama.2009.294.
10. Abed Y, Pizzorno A, Bouhy X, Boivin G. 2011. Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses. PLoS Pathog. 7:e1002431. http://dx.doi.org/10.1371/journal.ppat .1002431.
11. Bloom JD, Gong LI, Baltimore D. 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272-1275. http://dx.doi.org/10.1126/science.1187816.
12. Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y. 2012. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses. J. Virol. 86: 121-127. http://dx.doi.org/10.1128/JVI.06085-11.
13. Bouvier NM, Rahmat S, Pica N. 2012. Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivirresistant neuraminidase. J. Virol. 86:7268-7279. http://dx.doi.org/10 .1128/JVI.07242-12.
14. Bloom JD, Nayak JS, Baltimore D. 2011. A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase. PLoS One 6:e22201. http://dx .doi.org/10.1371/journal.pone.0022201.
15. Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr IG. 2012. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J. Infect. Dis. 206:148-157. http://dx.doi.org/10.1093/infdis/jis337.
16. Meijer A, Jonges M, van Beek P, Swaan CM, Osterhaus AD, Daniels RS, Hurt AC, Koopmans MP. 2012. Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012. Euro Surveill. 17(36):pii=20266. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20266.
17. Pizzorno A, Bouhy X, Abed Y, Boivin G. 2011. Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors. J. Infect. Dis. 203:25-31. http://dx.doi.org/10.1093/infdis/jiq010.
18. Yen HL, Ilyushina NA, Salomon R, Hoffmann E, Webster RG, Govorkova EA. 2007. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J. Virol. 81:12418-12426. http://dx.doi.org/10.1128/JVI.01067-07.
19. Abed Y, Goyette N, Boivin G. 2004. A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus. Antivir. Ther. 9:577-581. http://www.intmedpress.com/serveFile.cfm?sUID=6e16aa7b-7705-44ba-897a-2c80c1cc076f.
20. Gubareva LV. 2004. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res. 103:199-203. http://dx.doi.org/10.1016/j.virusres.2004.02.034.
21. Aoki FY, Boivin G, Roberts N. 2007. Influenza virus susceptibility and resistance to oseltamivir. Antivir. Ther. 12:603-616. http://www.intmedpress .com/serveFile.cfm?sUID=f23174a4-603e-477e-a576-004bf982bf3b.
22. Pizzorno A, Abed Y, Boivin G. 2011. Influenza drug resistance. Semin. Respir. Crit. Care Med. 32:409-422. http://dx.doi.org/10.1055/s-0031-1283281.
23. Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA. 2002. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res. 55:307-317. http://dx.doi.org/10.1016/S0166-3542(02)00053-0.
24. Herlocher ML, Truscon R, Elias S, Yen HL, Roberts NA, Ohmit SE, Monto AS. 2004. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J. Infect. Dis. 190:1627-1630. http://dx.doi.org/10.1086/424572.
25. Baz M, Abed Y, Simon P, Hamelin ME, Boivin G. 2010. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J. Infect. Dis. 201:740-745. http://dx.doi.org/10.1086/650464.
26. Duan S, Boltz DA, Seiler P, Li J, Bragstad K, Nielsen LP, Webby RJ, Webster RG, Govorkova EA. 2010. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog. 6:e1001022. http://dx.doi.org/10.1371/journal.ppat .1001022.
27. Seibert CW, Kaminski M, Philipp J, Rubbenstroth D, Albrecht RA, Schwalm F, Stertz S, Medina RA, Kochs G, Garcia-Sastre A, Staeheli P, Palese P. 2010. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J. Virol. 84:11219-11226. http://dx.doi.org/10.1128/JVI .01424-10.
28. Wong DD, Choy KT, Chan RW, Sia SF, Chiu HP, Cheung PP, Chan MC, Peiris JS, Yen HL. 2012. Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation. J. Virol. 86:10558-10570. http://dx.doi.org/10.1128/JVI.00985-12.
29. Hamelin ME, Baz M, Abed Y, Couture C, Joubert P, Beaulieu E, Bellerose N, Plante M, Mallett C, Schumer G, Kobinger GP, Boivin G. 2010. Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog. 6:e1001015. http://dx.doi.org/10.1371/journal.ppat.1001015.
30. Memoli MJ, Davis AS, Proudfoot K, Chertow DS, Hrabal RJ, Bristol T, Taubenberger JK. 2011. Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J. Infect. Dis. 203:348-357. http://dx.doi.org/10.1093/infdis/jiq067.
31. Kiso M, Shinya K, Shimojima M, Takano R, Takahashi K, Katsura H, Kakugawa S, Le MT, Yamashita M, Furuta Y, Ozawa M, Kawaoka Y. 2010. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog. 6:e1001079. http://dx.doi.org/10.1371/journal.ppat .1001079.
32. Hamelin ME, Baz M, Bouhy X, Beaulieu E, Dube K, Mallett C, Boivin G. 2011. Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets. Antivir. Ther. 16:775-779. http://dx.doi .org/10.3851/IMP1794.
33. Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM. 2012. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg. Infect. Dis. 18:308-311. http://dx.doi.org/10.3201/eid1802.111466.
34. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solorzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, Garcia-Sastre A. 2007.Atwo-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655-659. http://dx.doi.org/10.1126/science.1136212.
35. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M. 2009. Oseltamivirresistant influenza virus A (H1N1), Europe 2007-08 season. Emerg. Infect. Dis. 15:552-560. http://dx.doi.org/10.3201/eid1504.181280.